Wire · opportunities
Bracco and Avicenna.AI Announce FDA Clearance for UPTUNITY
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 November 2026 · Fusion42 review
Bracco and Avicenna.AI received FDA 510(k) clearance for UPTUNITY | Aneurysm, an AI-enabled software designed to assist radiologists in detecting and monitoring brain aneurysms on CT angiography images. This technology integrates into existing radiology workflows, providing detection, assessment, and follow-up capabilities for brain aneurysms larger than 3 mm.
This Wire brief sits within Fusion42's coverage of Health, and 4 sources have reported it.
◆ ◆ The Wire takeaway
You now have access to FDA-cleared AI software that fits into current radiology systems to detect and monitor brain aneurysms, opening opportunities to enhance diagnostic accuracy and patient follow-up. This clearance signals a growing acceptance of AI as a clinical decision tool that you can integrate into your product or service offerings.
◆ Coverage
4 sources · 13 Nov 2026
◆ Related on Wire
◆ Topics